Letter to the Editor: Patient-Reported Outcomes for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: Rationale for Expanded Use
Hepatology
.
2019 Jul;70(1):443-444.
doi: 10.1002/hep.30356.
Authors
Patrizia Carrieri
1
,
Martin Duracinsky
2
3
4
,
Fabienne Marcellin
1
,
Jeffrey V Lazarus
5
Affiliations
1
Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France.
2
AP-HP, Bicetre Hospital, Internal Medicine and Clinical Immunology Department, Le Kremlin-Bicetre, France.
3
AP-HP, Hotel-Dieu Hospital, Health Economics Clinical Trial Center, Paris, France.
4
University Paris-Diderot, Patient-Centered Outcomes Research, EA7334, Paris, France.
5
Barcelona Institute for Global Health (ISGlobal), Hospital Clinic, University of Barcelona, Barcelona, Spain.
PMID:
30472796
DOI:
10.1002/hep.30356
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Liver
Non-alcoholic Fatty Liver Disease*
Patient Reported Outcome Measures